Home / Funds / Voleon Capital Management LP
Voleon Capital Management LP
LEI 549300EJ1ZB4YYIOMD56 The short positions this fund discloses today, across every market.
8 open positions
4 Markets
July 27, 2026 Last disclosure
| Issuer | Market | % of capital | Since |
|---|---|---|---|
| Zealand Pharma A/S | Denmark | 1.11% | May 19, 2026 |
| B&M European Value Retail S.A. | Germany | 0.79% | April 20, 2026 |
| Oryzon Genomics, S.A. | Spain | 0.63% | July 3, 2026 |
| Gubra A/S | Denmark | 0.59% | March 23, 2026 |
| Lang & Schwarz Aktiengesellschaft | Germany | 0.59% | February 2, 2022 |
| SFC Energy AG | Germany | 0.59% | July 27, 2026 |
| Medigene AG | Germany | 0.55% | December 4, 2017 |
| Atos Group | France | 0.50% | July 21, 2026 |
History of disclosures
| Date | Issuer | Market | % of capital | End of publication |
|---|---|---|---|---|
| May 26, 2021 | Biophytis | France | 0.75% | June 18, 2021 |
| May 26, 2021 | Saf-Holland Gmbh | Germany | 0.69% | still open |
| May 25, 2021 | Navya | France | 0.99% | August 3, 2021 |
| May 25, 2021 | Eurotech SPA | Italy | 0.78% | still open |
| May 24, 2021 | Juventus Football Club SPA | Italy | 0.59% | still open |
| May 21, 2021 | Eurotech SPA | Italy | 0.88% | still open |
| May 21, 2021 | Gensight Biologics S.A. | France | 0.70% | August 25, 2021 |
| May 21, 2021 | Cell Impact AB (publ) | Sweden | 0.65% | still open |
| May 20, 2021 | Navya | France | 1.01% | August 3, 2021 |
| May 19, 2021 | Biophytis | France | 0.89% | June 18, 2021 |
| May 18, 2021 | Gensight Biologics S.A. | France | 0.62% | August 25, 2021 |
| May 18, 2021 | Erytech Pharma | France | 0.49% | still open |
| May 18, 2021 | Phaxiam Therapeutics | France | 0.49% | May 20, 2021 |
| May 17, 2021 | Saf-Holland Gmbh | Germany | 0.70% | still open |
| May 17, 2021 | Cell Impact AB (publ) | Sweden | 0.57% | still open |
| May 17, 2021 | Nicox SA | France | 0.48% | May 19, 2021 |
| May 14, 2021 | Metro Bank PLC | United Kingdom | 0.70% | still open |
| May 14, 2021 | Saf-Holland Gmbh | Germany | 0.63% | still open |
| May 13, 2021 | Eurotech SPA | Italy | 0.91% | still open |
| May 13, 2021 | Erytech Pharma | France | 0.57% | still open |
| May 13, 2021 | Phaxiam Therapeutics | France | 0.57% | May 20, 2021 |
| May 13, 2021 | Gensight Biologics S.A. | France | 0.52% | August 25, 2021 |
| May 12, 2021 | Navya | France | 0.90% | August 3, 2021 |
| May 12, 2021 | Saf-Holland Gmbh | Germany | 0.50% | still open |
| May 11, 2021 | Navya | France | 0.88% | August 3, 2021 |
| May 11, 2021 | Eurotech SPA | Italy | 0.83% | still open |
| May 11, 2021 | Quantum Genomics | France | 0.79% | June 14, 2021 |
| May 11, 2021 | Nicox SA | France | 0.59% | May 19, 2021 |
| May 10, 2021 | Erytech Pharma | France | 0.67% | still open |
| May 10, 2021 | Phaxiam Therapeutics | France | 0.67% | May 20, 2021 |
| May 10, 2021 | Duro Felguera, S.A. | Spain | 0.49% | still open |
| May 7, 2021 | Eurotech SPA | Italy | 0.78% | still open |
| May 7, 2021 | Solutions 30 SE | France | 0.68% | October 22, 2021 |
| May 7, 2021 | Cell Impact AB (publ) | Sweden | 0.63% | still open |
| May 6, 2021 | Quantum Genomics | France | 0.86% | June 14, 2021 |
| May 6, 2021 | Solutions 30 SE | France | 0.70% | October 22, 2021 |
| May 6, 2021 | Nicox SA | France | 0.67% | May 19, 2021 |
| May 6, 2021 | Juventus Football Club SPA | Italy | 0.61% | still open |
| May 5, 2021 | Metro Bank PLC | United Kingdom | 0.61% | still open |
| May 5, 2021 | Bayn Group AB | Sweden | 0.00% | still open |
| May 5, 2021 | Humble Group AB | Sweden | 0.00% | still open |
| May 4, 2021 | Eurotech SPA | Italy | 0.86% | still open |
| May 4, 2021 | Solutions 30 SE | France | 0.62% | October 22, 2021 |
| May 4, 2021 | Cell Impact AB (publ) | Sweden | 0.51% | still open |
| May 3, 2021 | Eurotech SPA | Italy | 0.94% | still open |
| April 30, 2021 | Eurotech SPA | Italy | 1.03% | still open |
| April 30, 2021 | Bayn Group AB | Sweden | 0.50% | still open |
| April 30, 2021 | Humble Group AB | Sweden | 0.50% | still open |
| April 29, 2021 | Eurotech SPA | Italy | 1.17% | still open |
| April 28, 2021 | Solutions 30 SE | France | 0.54% | October 22, 2021 |
| April 28, 2021 | Gensight Biologics S.A. | France | 0.49% | April 30, 2021 |
| April 28, 2021 | Cell Impact AB (publ) | Sweden | 0.00% | still open |
| April 27, 2021 | Juventus Football Club SPA | Italy | 0.50% | still open |
| April 26, 2021 | Quantum Genomics | France | 0.99% | June 14, 2021 |
| April 26, 2021 | Cell Impact AB (publ) | Sweden | 0.58% | still open |
| April 26, 2021 | Gensight Biologics S.A. | France | 0.50% | April 30, 2021 |
| April 26, 2021 | Solutions 30 SE | France | 0.49% | April 28, 2021 |
| April 22, 2021 | Erytech Pharma | France | 0.80% | still open |
| April 22, 2021 | Phaxiam Therapeutics | France | 0.80% | May 20, 2021 |
| April 20, 2021 | Eurotech SPA | Italy | 1.26% | still open |
| April 20, 2021 | Biophytis | France | 0.91% | June 18, 2021 |
| April 20, 2021 | Cell Impact AB (publ) | Sweden | 0.69% | still open |
| April 19, 2021 | Eurotech SPA | Italy | 1.34% | still open |
| April 19, 2021 | Biophytis | France | 0.83% | June 18, 2021 |
| April 19, 2021 | Metabolic Explorer | France | 0.48% | April 21, 2021 |
| April 16, 2021 | Erytech Pharma | France | 0.71% | still open |
| April 16, 2021 | Phaxiam Therapeutics | France | 0.71% | May 20, 2021 |
| April 16, 2021 | Duro Felguera, S.A. | Spain | 0.59% | still open |
| April 16, 2021 | Tecnicas Reunidas, S.A. | Spain | 0.49% | still open |
| April 16, 2021 | Immunovia AB (publ) | Sweden | 0.00% | still open |
| April 15, 2021 | Quantum Genomics | France | 1.08% | June 14, 2021 |
| April 15, 2021 | Cell Impact AB (publ) | Sweden | 0.79% | still open |
| April 15, 2021 | Metabolic Explorer | France | 0.51% | April 21, 2021 |
| April 14, 2021 | Cell Impact AB (publ) | Sweden | 0.83% | still open |
| April 14, 2021 | Duro Felguera, S.A. | Spain | 0.69% | still open |
| April 14, 2021 | Immunovia AB (publ) | Sweden | 0.59% | still open |
| April 13, 2021 | Navya | France | 0.95% | August 3, 2021 |
| April 13, 2021 | Cell Impact AB (publ) | Sweden | 0.91% | still open |
| April 13, 2021 | Duro Felguera, S.A. | Spain | 0.72% | still open |
| April 13, 2021 | Biophytis | France | 0.70% | June 18, 2021 |
| April 13, 2021 | Erytech Pharma | France | 0.61% | still open |
| April 13, 2021 | Phaxiam Therapeutics | France | 0.61% | May 20, 2021 |
| April 13, 2021 | Metabolic Explorer | France | 0.49% | April 15, 2021 |
| April 13, 2021 | Solocal Group | France | 0.45% | April 15, 2021 |
| April 12, 2021 | Navya | France | 1.16% | August 3, 2021 |
| April 12, 2021 | Biophytis | France | 0.89% | June 18, 2021 |
| April 12, 2021 | Immunovia AB (publ) | Sweden | 0.67% | still open |
| April 9, 2021 | Metro Bank PLC | United Kingdom | 0.59% | still open |
| April 9, 2021 | Solutions 30 SE | France | 0.50% | April 28, 2021 |
| April 8, 2021 | Navya | France | 1.39% | August 3, 2021 |
| April 8, 2021 | Biophytis | France | 0.97% | June 18, 2021 |
| April 8, 2021 | Erytech Pharma | France | 0.50% | still open |
| April 8, 2021 | Phaxiam Therapeutics | France | 0.50% | May 20, 2021 |
| April 7, 2021 | Eurotech SPA | Italy | 1.49% | still open |
| April 7, 2021 | Cell Impact AB (publ) | Sweden | 1.07% | still open |
| April 7, 2021 | Solocal Group | France | 0.57% | April 15, 2021 |
| April 7, 2021 | 4D Pharma PLC | United Kingdom | 0.42% | still open |
| April 7, 2021 | Oncopeptides AB | Sweden | 0.00% | still open |
| April 6, 2021 | Cell Impact AB (publ) | Sweden | 1.10% | still open |
| April 6, 2021 | Duro Felguera, S.A. | Spain | 0.84% | still open |
| April 6, 2021 | Immunovia AB (publ) | Sweden | 0.70% | still open |
| April 6, 2021 | Tecnicas Reunidas, S.A. | Spain | 0.57% | still open |
| April 6, 2021 | 4D Pharma PLC | United Kingdom | 0.52% | still open |
| April 6, 2021 | Maire SPA | Italy | 0.49% | still open |
| April 6, 2021 | Maire Tecnimont SPA | Italy | 0.49% | still open |
| April 6, 2021 | Digital Bros SPA | Italy | 0.45% | still open |
| April 1, 2021 | Eurotech SPA | Italy | 1.55% | still open |
| April 1, 2021 | Digital Bros SPA | Italy | 0.58% | still open |
| April 1, 2021 | 4D Pharma PLC | United Kingdom | 0.44% | still open |
| March 31, 2021 | Cell Impact AB (publ) | Sweden | 1.06% | still open |
| March 31, 2021 | Duro Felguera, S.A. | Spain | 0.74% | still open |
| March 31, 2021 | Digital Bros SPA | Italy | 0.65% | still open |
| March 31, 2021 | Tecnicas Reunidas, S.A. | Spain | 0.60% | still open |
| March 31, 2021 | Metabolic Explorer | France | 0.52% | April 15, 2021 |
| March 30, 2021 | Digital Bros SPA | Italy | 0.71% | still open |
| March 30, 2021 | Duro Felguera, S.A. | Spain | 0.64% | still open |
| March 30, 2021 | 4D Pharma PLC | United Kingdom | 0.58% | still open |
| March 30, 2021 | Oncopeptides AB | Sweden | 0.58% | still open |
| March 30, 2021 | Maire SPA | Italy | 0.50% | still open |
| March 30, 2021 | Maire Tecnimont SPA | Italy | 0.50% | still open |
| March 29, 2021 | Eurotech SPA | Italy | 1.66% | still open |
| March 29, 2021 | Digital Bros SPA | Italy | 0.81% | still open |
| March 29, 2021 | Oncopeptides AB | Sweden | 0.66% | still open |
| March 26, 2021 | 4D Pharma PLC | United Kingdom | 0.69% | still open |
| March 25, 2021 | Biophytis | France | 1.09% | June 18, 2021 |
| March 25, 2021 | Cell Impact AB (publ) | Sweden | 0.94% | still open |
| March 25, 2021 | Immunovia AB (publ) | Sweden | 0.60% | still open |
| March 24, 2021 | Biophytis | France | 1.10% | June 18, 2021 |
| March 24, 2021 | Nicox SA | France | 0.70% | May 19, 2021 |
| March 24, 2021 | Tecnicas Reunidas, S.A. | Spain | 0.50% | still open |
| March 23, 2021 | Metro Bank PLC | United Kingdom | 0.69% | still open |
| March 23, 2021 | Duro Felguera, S.A. | Spain | 0.52% | still open |
| March 22, 2021 | Navya | France | 1.41% | August 3, 2021 |
| March 22, 2021 | 4D Pharma PLC | United Kingdom | 0.75% | still open |
| March 19, 2021 | Eurotech SPA | Italy | 1.53% | still open |
| March 19, 2021 | 4D Pharma PLC | United Kingdom | 0.95% | still open |
| March 19, 2021 | Digital Bros SPA | Italy | 0.91% | still open |
| March 18, 2021 | Eurotech SPA | Italy | 1.44% | still open |
| March 18, 2021 | 4D Pharma PLC | United Kingdom | 0.84% | still open |
| March 18, 2021 | Metro Bank PLC | United Kingdom | 0.76% | still open |
| March 18, 2021 | Oncopeptides AB | Sweden | 0.70% | still open |
| March 17, 2021 | Digital Bros SPA | Italy | 0.85% | still open |
| March 17, 2021 | 4D Pharma PLC | United Kingdom | 0.76% | still open |
| March 17, 2021 | Nicox SA | France | 0.60% | May 19, 2021 |
| March 17, 2021 | Strategic Partners A/S | Denmark | 0.49% | March 17, 2021 |
| March 16, 2021 | Navya | France | 1.31% | August 3, 2021 |
| March 16, 2021 | Digital Bros SPA | Italy | 0.76% | still open |
| March 16, 2021 | Amoeba | France | 0.47% | March 18, 2021 |
| March 15, 2021 | Eurotech SPA | Italy | 1.30% | still open |
| March 15, 2021 | Quantum Genomics | France | 1.14% | June 14, 2021 |
| March 15, 2021 | Erytech Pharma | France | 0.49% | still open |
| March 15, 2021 | Phaxiam Therapeutics | France | 0.49% | March 23, 2021 |
| March 12, 2021 | Solocal Group | France | 0.61% | April 15, 2021 |
| March 12, 2021 | Oncopeptides AB | Sweden | 0.61% | still open |
| March 12, 2021 | 4D Pharma PLC | United Kingdom | 0.60% | still open |
| March 12, 2021 | Immunovia AB (publ) | Sweden | 0.57% | still open |
| March 12, 2021 | Nicox SA | France | 0.52% | May 19, 2021 |
| March 11, 2021 | Amoeba | France | 0.58% | still open |
| March 11, 2021 | Erytech Pharma | France | 0.57% | still open |
| March 11, 2021 | Phaxiam Therapeutics | France | 0.57% | March 23, 2021 |
| March 11, 2021 | Oncopeptides AB | Sweden | 0.53% | still open |
| March 10, 2021 | Quantum Genomics | France | 1.08% | June 14, 2021 |
| March 10, 2021 | Digital Bros SPA | Italy | 0.58% | still open |
| March 10, 2021 | 4D Pharma PLC | United Kingdom | 0.52% | still open |
| March 9, 2021 | Biophytis | France | 1.25% | June 18, 2021 |
| March 9, 2021 | Eurotech SPA | Italy | 1.25% | still open |
| March 9, 2021 | Erytech Pharma | France | 0.65% | still open |
| March 9, 2021 | Phaxiam Therapeutics | France | 0.65% | March 23, 2021 |
| March 8, 2021 | Eurotech SPA | Italy | 1.47% | still open |
| March 8, 2021 | Metro Bank PLC | United Kingdom | 0.87% | still open |
| March 8, 2021 | Digital Bros SPA | Italy | 0.63% | still open |
| March 8, 2021 | Solocal Group | France | 0.52% | April 15, 2021 |
| March 4, 2021 | Erytech Pharma | France | 0.70% | still open |
| March 4, 2021 | Phaxiam Therapeutics | France | 0.70% | March 23, 2021 |
| March 3, 2021 | Quantum Genomics | France | 0.92% | June 14, 2021 |
| March 3, 2021 | Borussia Dortmund Gmbh & CO. Kommanditgesellschaft AUF Aktien | Germany | 0.46% | still open |
| March 2, 2021 | Erytech Pharma | France | 0.72% | still open |
| March 2, 2021 | Amoeba | France | 0.60% | still open |
| March 2, 2021 | Borussia Dortmund Gmbh & CO. Kommanditgesellschaft AUF Aktien | Germany | 0.55% | still open |
| March 1, 2021 | Metro Bank PLC | United Kingdom | 0.91% | still open |
| March 1, 2021 | DBV Technologies | France | 0.49% | March 3, 2021 |
| February 26, 2021 | Digital Bros SPA | Italy | 0.48% | still open |
| February 25, 2021 | Eurotech SPA | Italy | 1.60% | still open |
| February 25, 2021 | Biophytis | France | 1.30% | June 18, 2021 |
| February 25, 2021 | Navya | France | 1.21% | August 3, 2021 |
| February 25, 2021 | Metro Bank PLC | United Kingdom | 0.80% | still open |
| February 25, 2021 | Betsson AB | Sweden | 0.00% | still open |
| February 24, 2021 | Navya | France | 0.94% | August 3, 2021 |
| February 24, 2021 | Metro Bank PLC | United Kingdom | 0.77% | still open |
| February 24, 2021 | Erytech Pharma | France | 0.69% | still open |
| February 24, 2021 | Phaxiam Therapeutics | France | 0.69% | March 23, 2021 |
| February 24, 2021 | DBV Technologies | France | 0.59% | March 3, 2021 |
| February 23, 2021 | Erytech Pharma | France | 0.70% | still open |
| February 23, 2021 | Phaxiam Therapeutics | France | 0.70% | March 23, 2021 |
| February 22, 2021 | Navya | France | 0.73% | August 3, 2021 |
| February 22, 2021 | DBV Technologies | France | 0.63% | March 3, 2021 |
| February 22, 2021 | Immunovia AB (publ) | Sweden | 0.60% | still open |
| February 22, 2021 | Strategic Partners A/S | Denmark | 0.58% | February 22, 2021 |
| February 19, 2021 | Metro Bank PLC | United Kingdom | 0.88% | still open |
| February 19, 2021 | Quantum Genomics | France | 0.81% | June 14, 2021 |
| February 19, 2021 | Borussia Dortmund Gmbh & CO. Kommanditgesellschaft AUF Aktien | Germany | 0.69% | still open |
| February 19, 2021 | Fingerprint Cards AB | Sweden | 0.00% | still open |
| February 18, 2021 | Biophytis | France | 1.29% | June 18, 2021 |
| February 18, 2021 | Navya | France | 0.83% | August 3, 2021 |
| February 18, 2021 | DBV Technologies | France | 0.77% | March 3, 2021 |
| February 18, 2021 | Immunovia AB (publ) | Sweden | 0.54% | still open |
| February 18, 2021 | Hoist Finance AB (publ) | Sweden | 0.00% | still open |
| February 17, 2021 | Biophytis | France | 1.14% | June 18, 2021 |
| February 17, 2021 | Erytech Pharma | France | 0.62% | still open |
| February 17, 2021 | Phaxiam Therapeutics | France | 0.62% | March 23, 2021 |
| February 16, 2021 | Metro Bank PLC | United Kingdom | 0.98% | still open |
| February 16, 2021 | DBV Technologies | France | 0.86% | March 3, 2021 |
| February 16, 2021 | Navya | France | 0.75% | August 3, 2021 |
| February 16, 2021 | Fingerprint Cards AB | Sweden | 0.55% | still open |
| February 16, 2021 | Betsson AB | Sweden | 0.50% | still open |
| February 16, 2021 | Vallourec | France | 0.44% | February 19, 2021 |
| February 15, 2021 | Eurotech SPA | Italy | 1.51% | still open |
| February 15, 2021 | DBV Technologies | France | 0.98% | March 3, 2021 |
| February 15, 2021 | Navya | France | 0.80% | August 3, 2021 |
| February 15, 2021 | Vallourec | France | 0.52% | February 19, 2021 |
| February 12, 2021 | Vallourec | France | 0.63% | February 19, 2021 |
| February 12, 2021 | Hoist Finance AB (publ) | Sweden | 0.55% | still open |
| February 12, 2021 | Erytech Pharma | France | 0.52% | still open |
| February 12, 2021 | Phaxiam Therapeutics | France | 0.52% | March 23, 2021 |
| February 11, 2021 | DBV Technologies | France | 1.06% | March 3, 2021 |
| February 11, 2021 | Biophytis | France | 1.00% | June 18, 2021 |
| February 11, 2021 | Vallourec | France | 0.76% | February 19, 2021 |
| February 11, 2021 | Fingerprint Cards AB | Sweden | 0.00% | still open |
| February 10, 2021 | Metro Bank PLC | United Kingdom | 1.09% | still open |
| February 10, 2021 | Digital Bros SPA | Italy | 0.53% | still open |
| February 9, 2021 | DBV Technologies | France | 1.17% | March 3, 2021 |
| February 9, 2021 | Cell Impact AB (publ) | Sweden | 1.06% | still open |
| February 9, 2021 | Vallourec | France | 0.89% | February 19, 2021 |
| February 9, 2021 | Navya | France | 0.70% | August 3, 2021 |
| February 8, 2021 | Metro Bank PLC | United Kingdom | 1.18% | still open |
| February 8, 2021 | Quantum Genomics | France | 0.71% | June 14, 2021 |
| February 8, 2021 | Fingerprint Cards AB | Sweden | 0.51% | still open |
| February 5, 2021 | Eurotech SPA | Italy | 1.48% | still open |
| February 5, 2021 | DBV Technologies | France | 1.26% | March 3, 2021 |
| February 5, 2021 | Metro Bank PLC | United Kingdom | 1.23% | still open |
| February 5, 2021 | Cell Impact AB (publ) | Sweden | 1.14% | still open |
| February 5, 2021 | Vallourec | France | 0.97% | February 19, 2021 |
| February 5, 2021 | Biophytis | France | 0.93% | June 18, 2021 |
| February 5, 2021 | Premier Foods | United Kingdom | 0.49% | still open |
| February 4, 2021 | Biophytis | France | 0.83% | June 18, 2021 |
| February 4, 2021 | Strategic Partners A/S | Denmark | 0.60% | February 4, 2021 |
| February 4, 2021 | Navya | France | 0.60% | August 3, 2021 |
| February 3, 2021 | Metro Bank PLC | United Kingdom | 1.38% | still open |
| February 3, 2021 | Cell Impact AB (publ) | Sweden | 1.25% | still open |
| February 3, 2021 | Borussia Dortmund Gmbh & CO. Kommanditgesellschaft AUF Aktien | Germany | 0.78% | still open |
The funds short on the same companies
- Citadel Advisors LLC 2 companies in common
- AHL Partners LLP 1 company in common
- Capital Fund Management 1 company in common
- Citadel Advisors II LLC 1 company in common
- Connor Clark & Lunn Investment Management Ltd 1 company in common
- D. E. Shaw & Co., L.P. 1 company in common
- Jennison Associates LLC 1 company in common
- Jupiter Asset Management Limited 1 company in common
- Marshall Wace LLP 1 company in common